Skip to content

Study On The Effect Of Tiktaka Ghrita Tarpana,Prasadana Putapaka, Kataka Khadiradi Ghana Vati In Diabetic Retinopathy

A Randomized Open Label Clinical Trial On the efficacy of Tiktaka Ghrita Tarpana, Prasadana Putapaka And Kataka Khadiradi Ghan Vati In Madumehajanya Timira With Special Reference To Diabetic Retinopathy

Status
Active, not recruiting
Phases
Phase 2
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2020/03/024341
Enrollment
30
Registered
2020-03-30
Start date
Unknown
Completion date
Unknown
Last updated
2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: H36- Retinal disorders in diseases classified elsewhere

Interventions

Intervention1: Kataka Khadiradi Ghan Vati 500 mg twice daily orally (Group A): This group will be treated with oral medication of Kataka Khadiradi Ghan Vati 500 mg twice daily orally before food for 3

Sponsors

Director National Institute of Ayurveda
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1. Known cases of Type I and Type II diabetes mellitus 2. Patients with well controlled blood sugar level 3. Patients with visual symptoms like blurring of vision, floaters etc 4. Patients with mild to moderate NPDR 5. Patients willing to give written consent

Exclusion criteria

Exclusion criteria: 1. Patients with severe NPDR or with PDR, Diabetic Maculopathy. 2. Patients with Diabetic Retinopathy with complications like Retinal detachment, posterior vitreal detachment, acute vitreal hemorrhage, RubiosisIridis. 3. Gestational Diabetic Retinopathy. 4. Severe visual impairments like high Myopia, Retinitis Pigmentosa, mature Cataract, post Cataract surgeries, Glaucoma. 5. Patients with other systemic complaints like Hypertension, Renal impairment, COPD, cardiovascular diseases.

Design outcomes

Primary

MeasureTime frame
Changes in Diabetic Retinopathy signs and symptoms as Blurred vision, Floaters and etcTimepoint: 2 Month

Secondary

MeasureTime frame
Procedures might show effect in headache, other eye problems such as Dry eye, Occular Stress, Concretions hence any associated incidental findings if found will be reported.Timepoint: 2 month

Countries

India

Contacts

Public ContactDr K S S P Fernando

National Institute of Ayurveda

shamsa_fiaz@yahoo.com8764009846

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026